Transthyretin Amyloidosis Treatment Market Size, Demand, Share 2024-2033

1
Transthyretin Amyloidosis Treatment Global Market
Report 2024
Global Forecast 2024 2033 Market Size, Drivers,
And Trends
Top Market Research Firm 2023! We are honored
to be listed as a top company at the forefront of
research, by the Business Management Review
2
Transthyretin Amyloidosis Treatment Market
Segments
The Business Research Company segments the
transthyretin amyloidosis treatment market report
as
Transthyretin Amyloidosis With Polyneuropathy
(ATTR-PN), Transthyretin Amyloidosis With
Cardiomyopathy (ATTR-CM)
By Type
Tafamidis, Patisiran, Inotersen, Other Drugs
By Drug
Targeted Therapy, Supportive Therapy, Pipeline
Therapy
By Therapy
By Distribution Channel
Hospital Pharmacies, Specialty Pharmacies, Retail
Pharmacies, Online Pharmacies
3
Market Statistics
The global Transthyretin Amyloidosis Treatment
market size grew from 5.07 billion in 2023 to
5.52 billion in 2024 at a compound annual growth
rate (CAGR) of 8.9.The Transthyretin Amyloidosis
Treatment market size is expected to grow
to 7.42 billion in 2028 at a compound annual
growth rate (CAGR) of 7.7.
7.42 B
5.52 B
5.07 B
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers
Rising investments in research and development
are expected to propel the growth of the
transthyretin amyloidosis treatment market going
forward.
Trends
Major companies in the transthyretin amyloidosis
treatment market focus on developing innovative
and specialized treatments, such as orphan drugs,
to enhance patient outcomes and expand treatment
options.
Region
North America was the largest region in the
Transthyretin Amyloidosis Treatment market in
2023. The regions covered in the Transthyretin
Amyloidosis Treatment market analysis report are
Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East and
Africa.
5
Top Eleven Players In The Market

• Major players in the market are
• Pfizer Inc.
• Abbvie Inc.
• Sanofi S.A.
• Bristol Myers Squibb Company
• AstraZeneca PLC
• GSK PLC

• Novo Nordisk A/S
• Merck Co. Inc.
• Astellas Pharma Inc.
• Alexion Pharmaceuticals Inc.
• Alnylam Pharmaceuticals Inc.

6
7 Reasons Why TBRC Is The Solution You Need

1. Global Macroeconomic Impact Assess global
   economic factors' influence on market growth.
2. Market Size Ratios Explore market size, GDP
   proportions, and expenditure per capita.
3. Global Perspective Reports cover 60 geographies
   for a comprehensive global understanding.
4. Localized Strategies Create region-specific
   strategies aligning with market nuances.
5. Investment Insights Identify growth segments
   through forecast data and market insights.
6. Competitor Benchmarking Compare performance
   against key competitors.
7. Presentation Support Reports offer reliable data
   for internal and external presentations.

7
Americas The Business Research Company, 1295 N
Providence Rd, Media, PA 19063, USA ? 1
3156230293
Get In Touch
Europe The Business Research Company 47 Anchorage
Point, 42 Cuba Street, Canary Wharf, London,
England, E14 8NE ? 44 207 1930 708
How ever you want to grow and expand, The
Business Research Company can help as we provide
research consulting solutions for businesses,
government agencies consultancies, and market
research companies.
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India),
500033 ? 91 8897263534
info_at_tbrc.info
8
Your Growth Insights Partner